Non-alcoholic fatty liver disease (NAFLD) is not rare among lean individuals. But in the absence of traditional risk factors, it remains under-recognized. At this JSH-AASLD session, experts unravel the latest data on lean-NASH prevalence in the general population. Speakers will also explore the influence of genetics and environment, and the impact of metabolic abnormalities in fibrosis development in lean-NASH.
New advances in management of liver disease during pregnancy present exciting opportunities and challenges for hepatologists co-managing this patient population. This session will provide key management updates on pertinent topics in pregnancy and liver disease, including a panel discussion of challenging cases in pregnancy, and highlight relevant recommendations from the upcoming AASLD Reproductive Health Guidance document.
Explore timely topics in liver disease in a lively debate format as pediatric and adult/general hepatology trainees and practicing hepatologists tackle important, often controversial issues. Debaters will gain skills in critical thinking, balanced argumentation and factual examination of each issue's pros and cons. Debaters, judges and audience members will grapple with opposing scientific, societal, individual and financial viewpoints on current clinical concerns.
Children's Hospital of Philadelphia vs Children's Hospital Colorado
Samuel J. Kesseli, Mariya L. Samoylova, John Yerxa, Carrie B. Moore, Marcelo Cerullo, Qimeng Gao, Nader Abraham, Yuval A. Patel, Lisa M. McElroy, Deepak Vikraman, Andrew S. Barbas – 14 November 2020 – Liver grafts from pediatric donors represent a small fraction of grafts transplanted into adult recipients, and their use in adults requires special consideration of donor size to prevent perioperative complications.
Mussarat N. Rahim, Shaolu Ran, Sital Shah, Sarah Hughes, Michael A. Heneghan – 14 November 2020
Yi‐Ming Lin, Ai‐Yong Cui, Da‐Wei Wang, Hua‐Ding Lu – 14 November 2020
The 2020 Hans Popper lecture reviews the cellular and molecular mechanisms of liver regeneration upon toxic injury, and how these mechanisms change in disease, mainly cancer. Learn how one lab combined animal and human organoid models, how to recapitulate key aspects of liver development and regeneration in vitro, and potential applications of these models in personalized medicine.
At this symposium, experts explore current controversies in transplant hepatology. An ethicist sets the stage with a lively discussion of current practices and challenges in patient and organ selection. Questions explored will include strategies to increase the donor pool, including living and altruistic donations, and the role of transplantation in patients with high-risk liver tumors and underlying mitochondrial disease.
Join this year's Career Development Workshop designed for both trainees interested in a hepatology career and early-career hepatologists. Participants will explore hepatology training pathways to different career opportunities, ranging from research to community-based practice. Participants will discuss the rewards and challenges of various careers, and strategies to maximize oneâs potential, including finding mentors.
What role does social media, the communications landscape that currently influences everything from politics to pop culture, play in hepatology and healthcare? This program will expose participants to different aspects of social media and encourage discussion ways that social media could advance the science and practice of hepatology.